Plaque reduction neutralization test

WikiDoc Resources for Plaque reduction neutralization test
Articles
Most recent articles on Plaque reduction neutralization test Most cited articles on Plaque reduction neutralization test Review articles on Plaque reduction neutralization test Articles on Plaque reduction neutralization test in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Plaque reduction neutralization test Images of Plaque reduction neutralization test Photos of Plaque reduction neutralization test Podcasts & MP3s on Plaque reduction neutralization test Videos on Plaque reduction neutralization test
Evidence Based Medicine
Cochrane Collaboration on Plaque reduction neutralization test Bandolier on Plaque reduction neutralization test TRIP on Plaque reduction neutralization test
Clinical Trials
Ongoing Trials on Plaque reduction neutralization test at Clinical Trials.gov Trial results on Plaque reduction neutralization test Clinical Trials on Plaque reduction neutralization test at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Plaque reduction neutralization test NICE Guidance on Plaque reduction neutralization test NHS PRODIGY Guidance FDA on Plaque reduction neutralization test CDC on Plaque reduction neutralization test
Books
Books on Plaque reduction neutralization test
News
Plaque reduction neutralization test in the news Be alerted to news on Plaque reduction neutralization test News trends on Plaque reduction neutralization test
Commentary
Blogs on Plaque reduction neutralization test
Definitions
Definitions of Plaque reduction neutralization test
Patient Resources / Community
Patient resources on Plaque reduction neutralization test Discussion groups on Plaque reduction neutralization test Patient Handouts on Plaque reduction neutralization test Directions to Hospitals Treating Plaque reduction neutralization test Risk calculators and risk factors for Plaque reduction neutralization test
Healthcare Provider Resources
Symptoms of Plaque reduction neutralization test Causes & Risk Factors for Plaque reduction neutralization test Diagnostic studies for Plaque reduction neutralization test Treatment of Plaque reduction neutralization test
Continuing Medical Education (CME)
CME Programs on Plaque reduction neutralization test
International
Plaque reduction neutralization test en Espanol Plaque reduction neutralization test en Francais
Business
Plaque reduction neutralization test in the Marketplace Patents on Plaque reduction neutralization test
Experimental / Informatics
List of terms related to Plaque reduction neutralization test

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The Plaque reduction neutralization test is used to quantify the titre of neutralising antibody for a virus.

The serum sample or solution of antibody to be tested is diluted and mixed with a viral suspension. This is incubated to allow the antibody to react with the virus. This is poured over a confluent monolayer of host cells. The surface of the cell layer is covered in a layer of agar or carboxymethyl cellulose to prevent the virus from spreading indiscriminately. The concentration of plaque forming units can be estimated by the number of plaques (regions of infected cells) formed after a few days. Depending on the virus, the plaque forming units are measured by microscopic observation, fluorescent antibodies or specific dyes that react with infected cells.

The concentration of serum to reduce the number of plaques by 50% compared to the serum free virus gives the measure of how much antibody is present or how effective it is. This measurement is denoted as the PRNT₅₀ value.

Currently it is considered to be the "gold standard" for detecting and measuring antibodies that can neutralise the viruses that cause many diseases. It has a higher sensitivity than other tests like hemagglutination and many commercial Enzyme immunoassay without compromising specificity.

However, the test is relatively cumbersome and time intensive (few days) relative to EIA kits that give quick results (usually several minutes to a few hours).

An issue with this assay that has recently been identified is that the neutralization ability of the antibodies is dependent on the virion maturation state and the cell-type used in the assay [4]. Therefore, if the wrong cell line is used for the assay it may seem that the antibodies have neutralization ability when they actually do not, or vice versa they may seem ineffective when they actually possess neutralization ability.

See Also

• ELISA